Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

6.66
Delayed Data
As of 3:59pm ET
 -0.15 / -2.20%
Today’s Change
5.06
Today|||52-Week Range
11.74
-4.86%
Year-to-Date
No recent news for Conatus Pharmaceuticals Inc.

Today’s Trading

Previous close6.81
Today’s open6.93
Day’s range6.60 - 6.93
Volume512,402
Average volume (3 months)682,206
Market cap$130.7M
Dividend yield--
Data as of 3:59pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)-128.57%
Earnings growth (this year)-6.02%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.19

Competitors

 Today’s
change
Today’s
% change
CAPRCapricor Therapeutic...-0.75-9.38%
STDYSteadymed Ltd-0.19-1.87%
MRNSMarinus Pharmaceutic...-0.04-0.44%
ARQLArQule Inc0.000.00%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$0.00
Annual profit (last year)-$22.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Steven J. Mento
Chief Financial Officer, Secretary &
SVP-Finance
Charles J. Cashion
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers